Cognitive Remediation Therapy in Schizophrenia: Effects on BDNF Levels

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
The main objective of the study is to analyse the role of a neurotrophic factor (BDNF) as a putative biological marker of the cognitive recovery in schizophrenia following a Cognitive Remediation Therapy (CRT). Additionally, the role as outcome predictors of BDNF serum levels and the Val66met polymorphism and data from functional and structural neuroimaging will be studied.
Epistemonikos ID: 58e00727cb190648786643ae70ca5ecacf807294
First added on: May 12, 2024